Rong Shi

1.9k citations
63 papers · 1.2k indexed · h-index 20
Topics
Gene expression and cancer classification (9 papers)RNA modifications and cancer (8 papers)MicroRNA in disease regulation (6 papers)
Partner nations
ChinaUnited StatesIsrael

In The Last Decade

Rong Shi

60 papers receiving 1.2k citations

Peers

Rong Shi
Comparison fields: 5 of 102
  • Molecular Biology 616
  • Cancer Research 547
  • Pulmonary and Respiratory Medicine 281
  • Oncology 268
  • Physiology 133
Replace Vivian W.Y. Wong with:
Vivian W.Y. Wong United States
Ya Zhou China
Kuang‐Hsiang Chuang United States
Prathibha Ranganathan India
A.E. Greijer Netherlands
Hongxia Z. Imtiyaz United States
Jiali Zhang China
Yueqi Wang China
Karla F. Meza‐Sosa Mexico
Rong Shi relative to Vivian W.Y. Wong United States Vivian W.Y. Wong's profile →
Citations per field
00.5×3.2×
Vivian W.Y. Wong · 1×
Citations per year

Countries citing papers authored by Rong Shi

Since Specialization
Citations

This map shows the geographic impact of Rong Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rong Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rong Shi more than expected).

Fields of papers citing papers by Rong Shi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rong Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rong Shi. The network helps show where Rong Shi may publish in the future.

Co-authorship network of co-authors of Rong Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Rong Shi. A scholar is included among the top collaborators of Rong Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rong Shi. Rong Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 10
2 9
3 0
4 6
5 4
6 10
7 32
8 43
9 85
10 22
11 52
12 18
13 51
14
Application of GIS Technology in Urban Planning
1
15 9
16 7
17 10
18 23
19
[Analysis with DNA chips of the changes of gene expressions in K562 cells in response to As2O3 treatment].
0
20 9

About Rong Shi

Rong Shi is a scholar working on Cancer Research, Aging and Molecular Biology, having authored 63 papers that have together received 1.2k indexed citations. Recurring topics across this work include Gene expression and cancer classification (9 papers), RNA modifications and cancer (8 papers) and MicroRNA in disease regulation (6 papers). The work is most often cited by research in Cancer Research (547 citations), Oncology (268 citations) and Molecular Biology (616 citations). Rong Shi has collaborated with scholars based in China, United States and Israel. Frequent co-authors include Wenli Ma, Jue‐Yu Zhou, Min Wei, Wenling Zheng, Wei Chen, Jun Zeng, Kun Ping Lu, Tae Ho Lee, Feng Lou and Lindsey Jones. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and PLoS ONE.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026